ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Enovis CORP
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 6, 2026
$19.87+0.28 (+1.43%)
Close on Oct 19, 2026
- Market cap
- $1.14B
- P/E (TTM)
- –
- Dividend yield
- –
Enovis CORP revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prevention & Recovery: | $1.14B | $1.10B | $1.08B | $1.03B | $1.03B | $863.15M | – | – | – | – | 50.6% | +3.6% |
| Reconstructive | $1.11B | $1.01B | $630.42M | $535.47M | $400.16M | $257.55M | – | – | – | – | 49.4% | +10.0% |
| Air and Gas Handling | – | – | – | – | – | – | – | – | – | $1.85B | – | – |
| Fabrication Technology | – | – | – | – | $2.43B | $1.95B | $2.25B | $2.19B | $1.94B | $1.80B | – | – |
| Air and Gas [Member] | – | – | – | – | – | – | – | $1.47B | $1.36B | $1.39B | – | – |
| Medical Technology | – | – | – | – | $1.43B | $1.12B | $1.08B | $0 | $0 | – | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fluid Handling | – | – | – | – | – | – | – | – | – | $461.29M | – | – |
| Air and gas handling | – | – | – | – | – | – | – | – | – | $1.39B | – | – |
| Welding and Cutting | – | – | – | – | – | – | – | – | – | $1.80B | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.30B | $1.25B | $1.15B | $1.06B | $1.03B | $839.97M | $1.46B | $540.53M | $478.34M | $794.01M | 57.6% | +4.0% |
| Foreign locations | $952.72M | $861.95M | $554.84M | $500.34M | $395.75M | $280.73M | $1.86B | $1.65B | $1.46B | $2.39B | 42.4% | +10.5% |
From the segment and revenue-disaggregation notes of Enovis's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.